Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2013-12-20 | Ms. Robyn C. Davis has been a director since June 2013. Since 2000 Ms. Davis has been Managing Director of AngelHealthcare Investors, LLC an early-stage private equity investment group focused on medical devices, life sciences and specialty pharmaceutical companies. ... The Board of Directors has concluded that Ms. Davis should continue to serve as a director of the Company because of her extensive business experience, particularly with early stage life sciences companies, and her banking and finance expertise. ... Committees: Audit Committee, Executive Committee, Human Resources and Compensation Committee. ... Compensation: $66,469. |
| 2014-12-19 | Ms. Robyn C. Davis has been a director since June 2013. Since 2000 Ms. Davis has been managing director of AngelHealthcare Investors, LLC, an early-stage private equity investment group focused on medical devices, life sciences and specialty pharmaceutical companies. ... The Board of Directors has concluded that Ms. Davis should continue to serve as a director of the Company because of her extensive business experience, particularly with early stage life sciences companies, and her banking and finance expertise. ... Committees: Audit (Member), Executive (Member), Human Resources and Compensation (Member). ... Compensation: $172,130. |
| 2015-12-11 | Ms. Davis has been managing director of AngelHealthcare Investors, LLC... The Board of Directors has concluded that Ms. Davis should continue to serve as a director of the Company because of her extensive business experience... Director Compensation Table: Robyn C. Davis $170,010. |
| 2016-12-16 | Ms. Davis has been managing director of AngelHealthcare Investors, LLC... The Board of Directors has concluded that Ms. Davis should continue to serve as a director of the Company because of her extensive business experience... Director Compensation Table shows total compensation of $170,003 for Ms. Davis. |
| 2017-12-13 | Ms. Davis has been managing director of AngelHealthcare Investors, LLC... The Board of Directors has concluded that Ms. Davis should continue to serve as a director of the Company because of her extensive business experience... Director Compensation Table: Robyn C. Davis $182,518 total compensation. |
| 2018-12-14 | Ms. Davis has been managing director of AngelHealthcare Investors, LLC... The Board of Directors has concluded that Ms. Davis should continue to serve as a director of the Company because of her extensive business experience... Director Compensation Table shows total compensation of $185,016. |
| 2019-12-17 | Ms. Davis has been managing director of AngelHealthcare Investors, LLC... The Board of Directors has concluded that Ms. Davis should continue to serve as a director of the Company because of her extensive business experience... The following table sets forth the total compensation paid or accrued during the fiscal year ended September 30, 2019 to each of our non-employee directors... Robyn C. Davis $215,022. |
| 2020-12-15 | Robyn C. Davis Nominee Information Ms. Davis has been managing director of AngelHealthcare Investors, LLC, an early-stage private equity investment group focused on medical devices, life sciences and specialty pharmaceutical companies, since 2000. Prior to AngelHealthcare, Ms. Davis was a director of the merchant banking services practices for Barents Group, LLC, and a strategy consultant at Bain & Company. Ms. Davis also serves as a director of two early-stage, privately held healthcare companies, Akston Bioscience Corporation and CRA Health, LLC. Ms. Davis holds an Executive Masters Professional Director Certification from the American College of Corporate Directors. Qualifications The Board of Directors has concluded that Ms. Davis should continue to serve as a director of the Company because of her extensive business experience, particularly with early stage life sciences companies, and her banking and finance expertise. Committees of the Board The Board currently has the following standing committees: an Audit Committee, an Executive Committee, a Finance Committee, a Human Resources and Compensation Committee, and a Nominating and Governance Committee. Robyn C. Davis serves on the Finance Committee and the Human Resources and Compensation Committee. Director Compensation Table Robyn C. Davis received total compensation of $222,534 in fiscal 2020. |
| 2021-12-15 | Ms. Davis has been a director of the Company since June 2013. Since 2000, she has served as Managing Director of AngelHealthcare Investors, LLC, an investment group focused on medical devices, life sciences and specialty pharmaceutical companies. Ms. Davis also serves as a corporate director of Psychemedics (PMD) and a director at Akston Biosciences, LLC. The Human Resources and Compensation Committee is currently comprised of Ms. Zane (Chair), Dr. Rosenblatt and Ms. Davis. Mses. Zane and Davis and Dr. Rosenblatt will remain on the Human Resources and Compensation Committee during fiscal 2022, if reelected by the stockholders. |
| 2022-12-21 | Robyn C. Davis Age: 61 Independent Director since June 2013 Committees • Finance (Chair) • Human Resources and Compensation Director Compensation Table Fiscal Year 2022 Robyn C. Davis $105,000 Fees Earned or Paid in cash $162,582 Stock Awards $267,582 Total |
| 2023-12-15 | Robyn C. Davis Age: 62 Independent Director since June 2013 Committees Current: • Finance (Chair) • Human Resources and Compensation Expected upon election at Annual Meeting: • Board Vice-Chair • Human Resources and Compensation (Chair) • Finance Compensation of Directors Table shows total compensation $278,754. |
| 2024-12-17 | Robyn C. Davis | Age 63 | (Director since June 2013) Committees: Human Resources and Compensation (Chair), Nominating and Governance Other Current Public Boards: Psychemedics Corporation (NASDAQ: PMD) Former Public Boards: None Education: BA, Tufts University; MBA, Harvard University; Executive Master Professional Director Certification, American College of Corporate Directors Career Highlights: Since 2000, Ms. Davis has served as Managing Director of AngelHealthcare Investors, a group comprised of Boston-based health and investment leaders. Ms. Davis manages the investment process and the portfolio of early-stage investments including medical devices, life sciences, information technology and professional services. She served on the boards of several portfolio companies and actively contributed to their fundraising, business model, and successful exit. Key Expertise Provided to the Board: Ms. Davis brings valuable investor-focused perspective to the Azenta Board and its ongoing efforts to maximize shareholder value. Ms. Davis also has strong financial acumen, particularly as it relates to operational matters and extensive experience supporting life sciences companies as they scale and grow, both organically and through mergers and acquisitions, having successfully exited certain portfolio companies and having sat on the Board of CRA Health when it was acquired by Volpara. Key Skills: Executive Leadership in Life Sciences/Healthcare, Risk and Investment Management, Operations Experience, Growth Strategy and Market Expansion, M&A and Integration Experience, Talent and Leadership Development, Public Company Director Experience Compensation: $277,517 total annual compensation. |
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-06 | Robyn C. Davis, 59, Director and Nominee, Member of Audit, Nominating and Compensation Committees |
| 2022-07-06 | Robyn C. Davis 60 Director and Nominee, Member of Audit, Nominating and Corporate Governance, and Compensation Committees ... Director Compensation for Fiscal Year Ended December 31, 2021 ... Robyn Davis $ 37,500 $ 86,130 $ - $ - $ - $ 123,630 |
| 2023-07-21 | Robyn C. Davis 61 Director and Nominee, Member of Audit, Nominating and Corporate Governance, and Compensation Committees Director Compensation for Fiscal Year Ended December 31, 2022 Robyn C. Davis Fees Earned or Paid in Cash: $50,000 Stock Awards: $78,120 Total: $128,120 |
| 2024-10-18 | Robyn C. Davis has been managing director of Angel Healthcare Investors, LLC, an early-stage investment group focused on medical devices, life sciences and specialty pharmaceutical companies since 2000. Additionally, Ms. Davis is a global Executive Coach at The Leadership Consortium. Prior to Angel Healthcare, Ms. Davis was a director of the merchant banking services practices for Barents Group, LLC, a strategy consultant at Bain & Company and a consultant at Computer Sciences Corporation. She currently serves as a director of Azenta Life Sciences (AZTA:Nasdaq-GS), a provider of life sciences sample management solutions, and Akston Biosciences, an early-stage company developing a novel fusion-protein platform for multiple conditions. Ms. Davis holds a B.A. in International Relations from Tufts University and an M.B.A from Harvard Business School. She holds an Executive Masters Professional Director Certification from the American College of Corporate Directors. As a result of these and other professional experiences, Ms. Davis possesses particular knowledge and experience in value-creation, growth strategy, cost reduction, and leadership development that strengthens the Board’s collective qualifications, skills and experience. Ms. Davis has been a director of the Company since 2021. Director and Nominee, Member of Nominating and Corporate Governance and Compensation Committees. Director Compensation for Fiscal Year Ended December 31, 2023: $112,460. |
Data sourced from SEC filings. Last updated: 2026-02-03